FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077269733> ?p ?o ?g. }

• W2077269733 endingPage "1663" @default.
• W2077269733 startingPage "1659" @default.
• W2077269733 abstract "Toll-like receptor-9 (TLR9) is a member of the innate immune system and recognizes bacterial and vertebrate DNA in cells. In addition to being expressed in cells of the immune system, it is widely expressed in various types of human cancer, including prostate cancer. We have previously demonstrated that synthetic TLR9 ligands induce invasion in TLR9-expressing prostate cancer cells in vitro. However, the role of TLR9 in the pathophysiology of prostate cancer is unclear. The expression of TLR9 in radical prostatectomy samples (n=186) was studied using immunohistochemistry. TLR9 staining scores were compared with tumor stage, Gleason score and prostate-specific antigen (PSA) concentration prior to treatment and progression-free survival. Results revealed that 124 (66.7%) of the tumors were strongly positive, 59 (31.7%) were weakly positive and 3 (1.6%) were negative, for cytoplasmic TLR9 immunostaining in cancer cells. There was no significant association between cytoplasmic TLR9 expression and distributions of pT-class, prostatectomy sample margin status, Gleason score and preoperative PSA value. Prostate cancer-specific progression-free survival was significantly longer for patients whose tumors were graded as negative for cytoplasmic TLR9 expression, as compared with patients whose tumors were strongly immunopositive for cytoplasmic TLR9 (P=0.009). In the Cox regression analysis, high TLR9 expression was an independent marker of poor prognosis in prostate cancer. Expression of TLR9 is associated with poor progression-free survival in prostate cancer patients who were treated by radical prostatectomy with curative intent." @default.
• W2077269733 created "2016-06-24" @default.
• W2077269733 creator A5026451028 @default.
• W2077269733 creator A5047749859 @default.
• W2077269733 creator A5049106949 @default.
• W2077269733 creator A5060735061 @default.
• W2077269733 creator A5084175334 @default.
• W2077269733 date "2013-02-20" @default.
• W2077269733 modified "2023-10-16" @default.
• W2077269733 title "Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer" @default.
• W2077269733 cites W1881101936 @default.
• W2077269733 cites W1966921390 @default.
• W2077269733 cites W1987979279 @default.
• W2077269733 cites W1992070627 @default.
• W2077269733 cites W1997332676 @default.
• W2077269733 cites W1998250923 @default.
• W2077269733 cites W2026122234 @default.
• W2077269733 cites W2030798978 @default.
• W2077269733 cites W2045384882 @default.
• W2077269733 cites W2072502256 @default.
• W2077269733 cites W2077995545 @default.
• W2077269733 cites W2083036309 @default.
• W2077269733 cites W2084060479 @default.
• W2077269733 cites W2084970540 @default.
• W2077269733 cites W2086584356 @default.
• W2077269733 cites W2113192348 @default.
• W2077269733 cites W2126030299 @default.
• W2077269733 cites W2128912176 @default.
• W2077269733 cites W2130138598 @default.
• W2077269733 cites W2132078058 @default.
• W2077269733 cites W2151393500 @default.
• W2077269733 cites W2156687447 @default.
• W2077269733 cites W2167438636 @default.
• W2077269733 cites W2168522148 @default.
• W2077269733 doi "https://doi.org/10.3892/ol.2013.1204" @default.
• W2077269733 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3678868" @default.
• W2077269733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23761830" @default.
• W2077269733 hasPublicationYear "2013" @default.
• W2077269733 type Work @default.
• W2077269733 sameAs 2077269733 @default.
• W2077269733 citedByCount "35" @default.
• W2077269733 countsByYear W20772697332014 @default.
• W2077269733 countsByYear W20772697332015 @default.
• W2077269733 countsByYear W20772697332016 @default.
• W2077269733 countsByYear W20772697332017 @default.
• W2077269733 countsByYear W20772697332018 @default.
• W2077269733 countsByYear W20772697332019 @default.
• W2077269733 countsByYear W20772697332020 @default.
• W2077269733 countsByYear W20772697332021 @default.
• W2077269733 countsByYear W20772697332022 @default.
• W2077269733 countsByYear W20772697332023 @default.
• W2077269733 crossrefType "journal-article" @default.
• W2077269733 hasAuthorship W2077269733A5026451028 @default.
• W2077269733 hasAuthorship W2077269733A5047749859 @default.
• W2077269733 hasAuthorship W2077269733A5049106949 @default.
• W2077269733 hasAuthorship W2077269733A5060735061 @default.
• W2077269733 hasAuthorship W2077269733A5084175334 @default.
• W2077269733 hasBestOaLocation W20772697331 @default.
• W2077269733 hasConcept C104317684 @default.
• W2077269733 hasConcept C121608353 @default.
• W2077269733 hasConcept C126322002 @default.
• W2077269733 hasConcept C142724271 @default.
• W2077269733 hasConcept C143998085 @default.
• W2077269733 hasConcept C150194340 @default.
• W2077269733 hasConcept C190727270 @default.
• W2077269733 hasConcept C204232928 @default.
• W2077269733 hasConcept C2776235491 @default.
• W2077269733 hasConcept C2779138994 @default.
• W2077269733 hasConcept C2779256057 @default.
• W2077269733 hasConcept C2779466945 @default.
• W2077269733 hasConcept C2780192828 @default.
• W2077269733 hasConcept C2781406297 @default.
• W2077269733 hasConcept C502942594 @default.
• W2077269733 hasConcept C55493867 @default.
• W2077269733 hasConcept C71924100 @default.
• W2077269733 hasConcept C86803240 @default.
• W2077269733 hasConcept C87874733 @default.
• W2077269733 hasConceptScore W2077269733C104317684 @default.
• W2077269733 hasConceptScore W2077269733C121608353 @default.
• W2077269733 hasConceptScore W2077269733C126322002 @default.
• W2077269733 hasConceptScore W2077269733C142724271 @default.
• W2077269733 hasConceptScore W2077269733C143998085 @default.
• W2077269733 hasConceptScore W2077269733C150194340 @default.
• W2077269733 hasConceptScore W2077269733C190727270 @default.
• W2077269733 hasConceptScore W2077269733C204232928 @default.
• W2077269733 hasConceptScore W2077269733C2776235491 @default.
• W2077269733 hasConceptScore W2077269733C2779138994 @default.
• W2077269733 hasConceptScore W2077269733C2779256057 @default.
• W2077269733 hasConceptScore W2077269733C2779466945 @default.
• W2077269733 hasConceptScore W2077269733C2780192828 @default.
• W2077269733 hasConceptScore W2077269733C2781406297 @default.
• W2077269733 hasConceptScore W2077269733C502942594 @default.
• W2077269733 hasConceptScore W2077269733C55493867 @default.
• W2077269733 hasConceptScore W2077269733C71924100 @default.
• W2077269733 hasConceptScore W2077269733C86803240 @default.
• W2077269733 hasConceptScore W2077269733C87874733 @default.
• W2077269733 hasIssue "5" @default.
• W2077269733 hasLocation W20772697331 @default.

• next